08:42 AM EST, 11/22/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Friday it has withdrawn its proposal to acquire Evotec (EVO) for 11 euro ($11.47) per share in cash.
Evotec did not immediately reply to a request for comment from MT Newswires.